Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Mini-Review Article

Antidiabetic Potential of Selected Ethnomedicines Utilized for the Management of Diabetes Mellitus in Trinidad and Tobago: A Review

Author(s): Yomica L. Powder-George* and Rajiv D. Deonarine

Volume 19, Issue 4, 2023

Published on: 21 July, 2022

Article ID: e190522205040 Pages: 8

DOI: 10.2174/1573399818666220519163350

Price: $65

Abstract

Background: Diabetes is a chronic metabolic disorder with a high global prevalence and one of the highest morbidity and mortality rates. Despite developments in synthetic medicine, the associated serious side effects with current antidiabetic drugs indicate an urgent need for novel effective treatments. Traditional medicinal plants offer great potential in the treatment of many diseases due to their bioactive phytochemicals and are a useful resource for developing safe and effective hypoglycemic agents.

Methods: The present review collates the most frequently used ethnomedicines for the management of diabetes mellitus in Trinidad and Tobago. Further, it provides scientific validation of the claimed antidiabetic effects of four selected ethnomedicines: Antigonon leptopus, Gomphrena globosa, Laportea aestuans and Stachytarpheta jamaicensis. A comprehensive literature search was conducted using various electronic scientific databases and search engines. Information was collected on the phytochemical and pharmacological aspects of these selected species to illustrate the antidiabetic activity and potential applications of these plants.

Conclusion: The findings of the numerous in vitro and in vivo experiments from previously published literature indicate the four candidate plants as promising sources of antidiabetic lead compounds and provide useful information to stimulate extensive studies. Further investigations on the isolation, identification and clinical evaluation of the pharmacologically active constituents from these plants can lead to the discovery of new and effective antidiabetic agents.

Keywords: Diabetes mellitus, antidiabetic, ethnomedicine, phytochemistry, pharmacological activity, hyperglycemia.

[1]
Lin X, Xu Y, Pan X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: An analysis from 1990 to 2025. Sci Rep 2020; 10(1): 14790.
[http://dx.doi.org/10.1038/s41598-020-71908-9] [PMID: 32901098]
[2]
Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 2008; 88(11): 1322-35.
[http://dx.doi.org/10.2522/ptj.20080008] [PMID: 18801863]
[3]
WHO. 2020.The top 10 causes of death. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (Accessed 09 Oct 2021).
[4]
IDF Diabetes Atlas (2021) Diabetes around the world in 2021. Available from: https://diabetesatlas.org/ Accessed 01 Nov 2021.
[5]
IDF North America and Caribbean members 2020. Available from: https://idf.org/our-network/regions-members/north-america-and-caribbean/members/73-trinidad-and-tobago.html (Accessed 09 Oct 2021).
[6]
WHO. (2018) Noncommunicable Diseases (NCD) Country Profiles, Trinidad and Tobago. Available from: https://www.who.int/nmh/countries/tto_en.pdf (Accessed 09 Oct 2021).
[7]
World Health Rankings. (2018) Trinidad and Tobago: Diabetes Mellitus. Available from: https://www.worldlifeexpectancy.com/trinidad-tobago- (Accessed 09 Oct 2021).
[8]
The Ministry of Health. Trinidad and Tobago (2017) National Strategic Plan for the Prevention and Control of Non Communicable Diseases: Trinidad and Tobago 2017–2021. Available from: https://www.psi.org/publication/national-strategic-plan-for-the-prevention-and-control-of-non-communicable-diseases-trinidad-and-tobago-2017-2021 (Accessed 09 Oct 2021).
[9]
Adeyemi TM, Olatunji TL, Adetunji AE, Rehal S. Knowledge, practice and attitude towards foot ulcers and foot care among adults living with diabetes in Tobago: A qualitative study. Int J Environ Res Public Health 2021; 18(15): 8021.
[http://dx.doi.org/10.3390/ijerph18158021] [PMID: 34360314]
[10]
Basu S, Flood D, Geldsetzer P, et al. Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model. Lancet Glob Health 2021; 9(11): e1539-52.
[http://dx.doi.org/10.1016/S2214-109X(21)00340-5] [PMID: 34562369]
[11]
Rafe MR. A review of five traditionally used anti-diabetic plants of Bangladesh and their pharmacological activities. Asian Pac J Trop Med 2017; 10(10): 933-9.
[http://dx.doi.org/10.1016/j.apjtm.2017.09.002] [PMID: 29111187]
[12]
Gaonkar VP, Hullatti K. Indian Traditional medicinal plants as a source of potent Anti-diabetic agents: A review. J Diabetes Metab Disord 2020; 19(2): 1895-908.
[http://dx.doi.org/10.1007/s40200-020-00628-8] [PMID: 33553046]
[13]
Mani JS, Johnson JB, Hosking H, et al. Antioxidative and therapeutic potential of selected Australian plants: A review. J Ethnopharmacol 2021; 268: 113580.
[http://dx.doi.org/10.1016/j.jep.2020.113580] [PMID: 33189842]
[14]
Nayak BS, Marshall JR, Isitor G, Adogwa A. Hypoglycemic and hepatoprotective activity of fermented fruit juice of Morinda citrifolia (Noni) in diabetic rats. Evid Based Complement Alternat Med 2011; 2011: 875293.
[http://dx.doi.org/10.1155/2011/875293] [PMID: 20981320]
[15]
Mahabir D, Gulliford MC. Use of medicinal plants for diabetes in Trinidad and Tobago. Rev Panam Salud Publica 1997; 1(3): 174-9.
[http://dx.doi.org/10.1590/S1020-49891997000300002] [PMID: 9128111]
[16]
Lans CA. Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus. J Ethnobiol Ethnomed 2006; 2: 45.
[http://dx.doi.org/10.1186/1746-4269-2-45] [PMID: 17040567]
[17]
Clement YN, Baksh-Comeau YS, Seaforth CE. An ethnobotanical survey of medicinal plants in Trinidad. J Ethnobiol Ethnomed 2015; 11: 67.
[http://dx.doi.org/10.1186/s13002-015-0052-0] [PMID: 26369926]
[18]
Haber EA, Santos MJ, Leitão PJ, et al. High spatial resolution mapping identifies habitat characteristics of the invasive vine Antigonon leptopus on St. Eustatius (Lesser Antilles). Biotropica 2021; 53: 941-53.
[http://dx.doi.org/10.1111/btp.12939]
[19]
Raghavendra HL. Medicinal uses, phytochemistry and pharmacological activities of Antigonon leptopus Hook. and Arn. (Polygonaceae): A review. J Chem Pharm Res 2018; 10: 103-10.
[20]
Musthafa MM, Nastaran AD, Marikar FM, Rajandram D, Ahmed AB. Phytochemical, pharmaceutical and biochemical activities of selected climber plants: A review. Annu Res Rev Biol 2017; 16: 1-22.
[http://dx.doi.org/10.9734/ARRB/2017/34796]
[21]
Ramadan NA. GC-MS analysis of the methylene chloride and nbutanol fractions of the methanolic extract of Antigonon leptopus (Hook & Arn.). Extraction 2018; 5: 219-22.
[22]
Vanisree M, Alexander-Lindo RL, DeWitt DL, Nair MG. Functional food components of Antigonon leptopus tea. Food Chem 2008; 106: 487-92.
[http://dx.doi.org/10.1016/j.foodchem.2007.06.013]
[23]
Mulabagal V, Alexander-Lindo RL, Dewitt DL, Nair MG. Health-beneficial phenolic aldehyde in Antigonon leptopus tea. Evid Based Complement Alternat Med 2011; 2011: 601249.
[http://dx.doi.org/10.1093/ecam/nep041] [PMID: 19454555]
[24]
Minocha PK, Masood M, Tiwari KP. 1,6,8-Trimethoxy-3 propanoyl anthraquinone a new pigment from the flowers of Antigonon Leptopus Hook and Arn. Indian J Chem 1981; 20B: 251-2.
[http://dx.doi.org/10.1007/978-94-017-8748-2_49]
[25]
Apaya MK, Chichioco-Hernandez CL. New steroidal saponin from Antigonon leptopus Hook. and Arn. Pharmacogn Mag 2014; 10 (Suppl. 3): S501-5.
[http://dx.doi.org/10.4103/0973-1296.139781] [PMID: 25298666]
[26]
Olaoluwa OO, Aiyelaagbe OO, Irwin D, Reid M. Novel anthraquinone derivatives from the aerial parts of Antigonon leptopus Hook & Arn. Tetrahedron 2013; 69: 6906-10.
[http://dx.doi.org/10.1016/j.tet.2013.05.014]
[27]
Angothu S, Lakshmi SM, Kumar AS, Reddy KY. Antidiabetic activity of aerial parts of Antigonon leptopus Hook & Arn in alloxan-induced diabetic rats. Int J Phytopharm 2010; 1: 28-34.
[28]
Kavatagimath SA, Jalalpure SS, Hiremath RD, Kempwade AA. In-vivo screening of ethanolic extract of Antigonon leptopus flower for anti-diabetic and antioxidant potential. Indian J Pharm Educ Res 2020; 54: S261-8.
[http://dx.doi.org/10.5530/ijper.54.2s.82]
[29]
Rani SV, Sujatha S, Krishna MG, Ravi KB. Antidiabetic effect of Antigonon leptopus Hook & Arn leaf on streptozotocin-induced diabetic rats. Pharmacologyonline 2010; 2: 922-31.
[30]
Vandebroek I, Picking D, Aiken S, et al. A review of Coralilla (Antigonon leptopus): An invasive and popular urban bush medicine in Jamaica. Econ Bot 2018; 72: 229-45.
[http://dx.doi.org/10.1007/s12231-018-9415-5]
[31]
Gangarao B, Raju NJ. Studies in preliminary phytochemical and antimicrobial activity of Antigonon leptopus Hook. Int J Chem Sci 2009; 7: 2900-4.
[32]
Kiranmayi GV. Phytochemical investigation, in vitro antioxidant, and in vivo antidepressant activity of ethanolic leaf extract Antigonon leptopus. Int J Green Pharm 2018; 12(1): P8.
[http://dx.doi.org/10.22377/ijgp.v12i01.1626]
[33]
Ranjan P, Tiwari DK, Tripathi K. Evaluation of antidepressant activity of ethanol and chloroform extracts of Antigonon leptopus. European J Biomed Pharmaceut Sci 2015; 2: 366-75.
[34]
Swaroopa RV, Swetha U. Effect of root extract fractions of Antigonon leptopus Hook. et ARN. on antioxidant activity. Int J Pharm Biol Sci 2019; 9: 612-8.
[35]
Carey MW, Babu DJ, Rao NV, Mohan GK. Study of anti-inflammatory activity of Antigonon leptopus Hook. et Arn roots. J Pharm Chem 2008; 2: 133-8.
[36]
Poosa M, Vanapatla SR. Protective effect of Antigonon leptopus (Hook et. Arn) in cadmium induced hepatotoxicity and nephrotoxicity in rats. Clin Phytoscience 2020; 6: 1-8.
[http://dx.doi.org/10.1186/s40816-020-00181-0]
[37]
Rao BG, Nath MS, Raju NJ. Hepatoprotective activity of roots and rhizomes of Antigonon leptopus Hook. Int J Chem Sci 2009; 7: 273-6.
[38]
Kanthal L, Divija V, Dhanalakshmi D, et al. In-vitro cytotoxic activity and anthelmintic effect of chloroform extract of Antigonon leptopus Hook & Arn. Pharma Chem 2016; 8: 129-33.
[39]
Roriz CL, Barros L, Prieto MA, Barreiro MF, Morales P, Ferreira IC. Modern extraction techniques optimized to extract betacyanins from Gomphrena globosa L. Ind Crops Prod 2017; 105: 29-40.
[http://dx.doi.org/10.1016/j.indcrop.2017.05.008]
[40]
Roriz CL, Barros L, Prieto MA, et al. Enhancing the antimicrobial and antifungal activities of a coloring extract agent rich in betacyanins obtained from Gomphrena globosa L. flowers. Food Funct 2018; 9(12): 6205-17.
[http://dx.doi.org/10.1039/C8FO01829D] [PMID: 30467561]
[41]
Esmat AU, Mittapally S. A review on Gomphrena globosa (L). Int J Res Ayurveda Pharm 2020; 11: 78-84.
[http://dx.doi.org/10.7897/2277-4343.110366]
[42]
Esmat AU, Mittapally S, Begum S. GC-MS analysis of bioactive compounds and phytochemical evaluation of the ethanolic extract of Gomphrena globosa L. Flowers. J Drug Deliv Ther 2020; 10: 53-8.
[http://dx.doi.org/10.22270/jddt.v10i2.3914]
[43]
Dinda B, Ghosh B, Arima S, Sato N, Harigaya Y. Phytochemical investigation of Gomphrena globosa aerial parts. Indian J Chem Sect B: Organic Chemistry, Including. Medical Chemistry 2004; 43: 2223-7.
[44]
Dinda B, Ghosh B, Achari B, Arima S, Sato N, Harigaya Y. Chemical constituents of Gomphrena globosa. II. Nat Prod Sci 2006; 12: 89-93.
[45]
Latha ST, Rajendran NN. Apoptosis effect of isolated phenolic secoiridoid glucoside from aerial parts of Gomphrena Globosa in A-431cell lines. World J Pharm Pharm Sci 2013; 2: 3829-39.
[46]
Sherif AT. In vitro antidiabetic, antioxidant and antiglycation activity of ethanolic leaf extract of Gomphrena globosa (Linn.). Asian J Biol Life Sci 2021; 10: 101-9.
[http://dx.doi.org/10.5530/ajbls.2021.10.16]
[47]
Sherif AT. In vitro evaluation of purple inflorescence of Gomphrena globosa (L.) extracts for anti-inflammatory activity and its GC/MS profile. Asian J Biol Life Sci 2021; 10: 123.
[http://dx.doi.org/10.5530/ajbls.2021.10.19]
[48]
Lakshman K, Bhat V, Archana VR, Ashok KBS, Girija K. Antioxidant potential of leaves of Gomphhrena globosa. European J Biomed Pharm Sci 2020; 7: 365-8.
[49]
Lakshman K, Bhat V, Archana VR. Evaluation of antiurolithiatic potential of leaves of Gomphhrena globosa. World J Pharm Pharm Sci 2020; 9: 1202-9.
[50]
Oloyede GK, Oyelola MS. Chrysen-2-ol derivative from West Indian Wood Nettle Laportea aestuans (L.) Chew inhibits oxidation and microbial growth in vitro. EXCLI J 2013; 12: 894-906.
[http://dx.doi.org/10.17877/DE290R-7569] [PMID: 27092035]
[51]
Okereke S, Elekwa I, Nmaju A. Gas chromatographic fid, hypoglycemic and hypolipidemic effects of leaves of Laportea aestuans in alloxan induced diabetes in male albino rats. IOSR J Environ Sci Toxicol Food Technol 2014; 42: 42-6.
[52]
Oloyede GK. Toxicity, antimicrobial and antioxidant activities of methyl salicylate dominated essential oils of Laportea aestuans (Gaud). Arab J Chem 2016; 9: S840-5.
[http://dx.doi.org/10.1016/j.arabjc.2011.09.019]
[53]
Adetunji OA, Olugbami JO, Adegoke AM, Gbadegesin MA, Odunola OA. Reno-hepatoprotective and antidiabetic properties of methanol leaf extract of Laportea aestuans in Wistar rats. J Evid Based Integr Med 2021; 26: X211017464.
[http://dx.doi.org/10.1177/2515690X211017464] [PMID: 34039071]
[54]
Abiola TS, Opajobi IC, Babalola OO. Protective effect of methanolic extract of Laportea aestuans on indomethacin-induced kidney damage in male wistar rats. E3 J Environ Res and Manage 2019; 10: 5-11.
[55]
Aladesanmi AJ, Famuyiwa FG, Oriola AO, Oguntimehin SA, Aiyedun PO, Arthur G. Cytotoxic activity of selected Nigerian medicinal plants. J Herbs Spices Med Plants 2020; 26: 203-17.
[http://dx.doi.org/10.1080/10496475.2019.1706214]
[56]
Simaremare ES, Holle E, Gunawan E, Yabansabra YR, Octavia F, Pratiwi RD. Toxicity, antioxidant, analgesic and anti-inflammatory properties of ethanol extracts of Laportea aestuans (Linn.) chew. J Chem Pharm Res 2018; 10: 16-23.
[57]
Elizabeth OO, Olawumi OO. Therapeutic effect of methanolic extract of Laportea aestuans (L.) Chew, on oxidative stress in the brain of male Wistar rats. AIP Conference Proceedings. AIP Publishing LLC 2018; 1954: p. (1): 040008.
[http://dx.doi.org/10.1063/1.5033408]
[58]
Christensen CB, Soelberg J, Jäger AK. Antacid activity of Laportea aestuans (L.) Chew. J Ethnopharmacol 2015; 171: 1-3.
[http://dx.doi.org/10.1016/j.jep.2015.05.026] [PMID: 26023029]
[59]
Okereke SC, Elekwa I. Studies on the in vitro antioxidant activity of Laportea aestuans leaf extract. IOSR J Environ Sci Toxicol Food Technol 2014; 8: 33-41.
[http://dx.doi.org/10.9790/2402-08123341]
[60]
Liew PM, Yong YK. Stachytarpheta jamaicensis (L.) Vahl: from traditional usage to pharmacological evidence. Evid Based Complement Alternat Med 2016; 2016: 7842340.
[http://dx.doi.org/10.1155/2016/7842340] [PMID: 26925152]
[61]
Estella OU, Sangwan PL. Isolation and characterization of ursolic acid, apigenin and luteolin from leaves of Stachytarpheta jamaicensis (L) Vahl. (Verbennaceae) from tropical forest of eastern Nigeria 2020; 9: 11-24.
[62]
Calista C, Tjipto MS, Putro JN, et al. Supercritical CO2 extraction of bioactive compounds from Stachytarpheta jamaicensis (L). Vahl Int Food Res J 2016; 23: 2144-50.
[63]
Okwu DE, Ohenhen ON. Isolation, characterization and antibacterial activity of lanostane triterpenoid from the leaves of Stachyterpheta jamaicensis Linn Vahl. Der Pharm Chem 2009; 1: 32-9.
[64]
Okwu DE, Ohenhen ON. Isolation, characterization and antibacterial activity of a lanostane triterpenoid from the stem bark of Stachyterpheta jamaicensis Linn Vahl. J Chem Soc Nigeria 2009; 34: 31-7.
[65]
Rozianoor MW, Eizzatie YN, Nurdiana S. Hypoglycemic and antioxidant activities of Stachytarpheta jamaicensis ethanolic leaves extract on alloxan-induced diabetic sprague dawley rats. BioTechnol 2014; 9: 423-8.
[66]
Rozianoor MW, Nadia KN, Nurdiana S. Stachytarpheta jamaicensis ethanolic leaf extract as wound healer on alloxan-induced diabetic sprague dawley rats. Biotechnology (Rajkot) 2014; 9: 460-6.
[67]
Pandian C, Srinivasan A, Pelapolu IC. Evaluation of wound healing activity of hydroalcoholic extract of leaves of Stachytarpheta jamaicensis in streptozotocin induced diabetic rats. Pharm Lett 2013; 5: 193-200.
[68]
Thangiah AS. Phytochemical screening and antimicrobial evaluation of ethanolic-aqua extract of Stachytarpheta jamaicensis (L.) Vahl leaves against some selected human pathogenic bacteria. Rasayan J Chem 2019; 12: 300-7.
[http://dx.doi.org/10.31788/RJC.2019.1215042]
[69]
Widiyastuti Y, Sholikhah IY, Haryanti S. Cytotoxic activities of ethanolic and dichloromethane extract of leaves, stems, and flowers of Jarong [Stachytarpheta jamaicensis (L.) Vahl.] on HeLa and T47D cancer cell line. AIP Conference Proceedings. AIP Publishing LLC. 2019; 2202: p. 020101.
[http://dx.doi.org/10.1063/1.5141714]
[70]
Amaechina FC, Bafor EE. In vitro inhibitory effect of methanol leaf extract of Stachytarpheta jamaicensis (Verbenaceae) on nonpregnant rat uterus. Trop J Pharm Res 2016; 15: 2557-62.
[http://dx.doi.org/10.4314/tjpr.v15i12.4]
[71]
Eskander DM, Aziz WM, Nassar MI, Hamed MA. Isolation and characterization of flavonoid compounds from Stachytarpheta jamaicensis (L.) Vahl and its role as anti-gastro ulcerative agent in rats. Biomarkers 2021; 26(7): 606-16.
[http://dx.doi.org/10.1080/1354750X.2021.1950210] [PMID: 34229545]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy